![]() |
Volumn 339, Issue 7720, 2009, Pages 527-
|
QRISK validation and evaluation: Bespoke cohort studies needed
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
ANTIHYPERTENSIVE THERAPY;
BLOOD PRESSURE;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL PRACTICE;
HYPERTENSION;
LETTER;
PHYSICIAN;
PRIORITY JOURNAL;
RISK ASSESSMENT;
COHORT ANALYSIS;
HUMAN;
NOTE;
REPRODUCIBILITY;
RISK FACTOR;
CARDIOVASCULAR DISEASES;
COHORT STUDIES;
HUMANS;
REPRODUCIBILITY OF RESULTS;
RISK FACTORS;
|
EID: 69949085802
PISSN: None
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.b3512 Document Type: Letter |
Times cited : (4)
|
References (3)
|